Kossan Rubber Industries Bhd (KSRBF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 647.62 Million MYR | -71.18% |
| 2022 | 765.37 Million MYR | -12.98% |
| 2021 | 879.5 Million MYR | 23.69% |
| 2020 | 711.04 Million MYR | 18.24% |
| 2019 | 601.35 Million MYR | -7.97% |
| 2018 | 653.46 Million MYR | 17.21% |
| 2017 | 557.5 Million MYR | 7.32% |
| 2016 | 519.47 Million MYR | 3.27% |
| 2015 | 503 Million MYR | 18.82% |
| 2014 | 423.33 Million MYR | 10.16% |
| 2013 | 384.31 Million MYR | 24.29% |
| 2012 | 309.19 Million MYR | 25.85% |
| 2011 | 245.67 Million MYR | 2.79% |
| 2010 | 239 Million MYR | -4.84% |
| 2009 | 251.14 Million MYR | 35.96% |
| 2008 | 184.71 Million MYR | 23.41% |
| 2007 | 149.68 Million MYR | 19.1% |
| 2006 | 125.67 Million MYR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | -12.54 Million MYR | -104.32% |
| 2024 Q1 | 410.58 Million MYR | 176.02% |
| 2023 Q4 | -540.13 Million MYR | -252.43% |
| 2023 Q2 | 401.23 Million MYR | -6.61% |
| 2023 Q3 | 354.34 Million MYR | -11.69% |
| 2023 FY | 220.57 Million MYR | -71.18% |
| 2023 Q1 | 429.65 Million MYR | 148.2% |
| 2022 Q3 | 544.36 Million MYR | 2.01% |
| 2022 Q1 | 578.81 Million MYR | 141.6% |
| 2022 FY | 765.37 Million MYR | -12.98% |
| 2022 Q4 | -891.44 Million MYR | -263.76% |
| 2022 Q2 | 533.64 Million MYR | -7.8% |
| 2021 Q1 | 819.71 Million MYR | 186.2% |
| 2021 Q2 | 837.85 Million MYR | 2.21% |
| 2021 FY | 879.5 Million MYR | 23.69% |
| 2021 Q3 | 613.36 Million MYR | -26.79% |
| 2021 Q4 | -1.39 Billion MYR | -326.85% |
| 2020 Q3 | 597.08 Million MYR | 10.86% |
| 2020 Q2 | 538.6 Million MYR | 2.33% |
| 2020 Q1 | 526.31 Million MYR | 163.97% |
| 2020 Q4 | -950.96 Million MYR | -259.27% |
| 2020 FY | 711.04 Million MYR | 18.24% |
| 2019 Q3 | 466.31 Million MYR | -1.99% |
| 2019 Q2 | 475.77 Million MYR | -1.31% |
| 2019 Q4 | -822.8 Million MYR | -276.45% |
| 2019 FY | 601.35 Million MYR | -7.97% |
| 2019 Q1 | 482.1 Million MYR | 167.87% |
| 2018 FY | 653.46 Million MYR | 17.21% |
| 2018 Q4 | -710.29 Million MYR | -242.69% |
| 2018 Q3 | 497.79 Million MYR | 13.61% |
| 2018 Q2 | 438.16 Million MYR | 2.56% |
| 2018 Q1 | 427.22 Million MYR | 157.46% |
| 2017 FY | 557.5 Million MYR | 7.32% |
| 2017 Q4 | -743.47 Million MYR | -273.76% |
| 2017 Q3 | 427.86 Million MYR | -0.92% |
| 2017 Q2 | 431.85 Million MYR | -2.13% |
| 2017 Q1 | 441.25 Million MYR | 181.08% |
| 2016 Q2 | 350.42 Million MYR | 1.83% |
| 2016 FY | 519.47 Million MYR | 3.27% |
| 2016 Q1 | 344.11 Million MYR | 169.32% |
| 2016 Q4 | -544.2 Million MYR | -247.43% |
| 2016 Q3 | 369.13 Million MYR | 5.34% |
| 2015 Q4 | -496.43 Million MYR | -234.81% |
| 2015 Q3 | 368.24 Million MYR | 13.95% |
| 2015 FY | 503 Million MYR | 18.82% |
| 2015 Q1 | 308.01 Million MYR | 182.86% |
| 2015 Q2 | 323.17 Million MYR | 4.92% |
| 2014 Q2 | 257.09 Million MYR | -0.1% |
| 2014 Q1 | 257.33 Million MYR | 156.34% |
| 2014 Q4 | -371.72 Million MYR | -232.46% |
| 2014 FY | 423.33 Million MYR | 10.16% |
| 2014 Q3 | 280.63 Million MYR | 9.16% |
| 2013 Q2 | 275.86 Million MYR | -1.81% |
| 2013 Q4 | -456.74 Million MYR | -260.69% |
| 2013 FY | 384.31 Million MYR | 24.29% |
| 2013 Q1 | 280.94 Million MYR | 155.82% |
| 2013 Q3 | 284.24 Million MYR | 3.04% |
| 2012 Q1 | 259.15 Million MYR | 0.0% |
| 2012 FY | 309.19 Million MYR | 25.85% |
| 2012 Q2 | 272.11 Million MYR | 5.0% |
| 2012 Q3 | 281.21 Million MYR | 3.35% |
| 2012 Q4 | -503.29 Million MYR | -278.97% |
| 2011 FY | 245.67 Million MYR | 2.79% |
| 2010 FY | 239 Million MYR | -4.84% |
| 2009 FY | 251.14 Million MYR | 35.96% |
| 2008 FY | 184.71 Million MYR | 23.41% |
| 2007 FY | 149.68 Million MYR | 19.1% |
| 2006 FY | 125.67 Million MYR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -22517.955% |
| Ansell Limited | 495.5 Million USD | -30.702% |
| Ansell Limited | 495.5 Million USD | -30.702% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -682.121% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -37318.677% |
| Psykey, Inc. | 1.21 Million USD | -53269.318% |
| ConvaTec Group Plc | 910.31 Million USD | 28.857% |
| ConvaTec Group Plc | 872.5 Million USD | 25.774% |
| Encision Inc. | 3.77 Million USD | -17047.729% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -456582.486% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -589020.448% |
| Innovative MedTech Inc. | 6.09 Million USD | -10518.559% |
| LifePoint, Inc. | 7.42 Million USD | -8623.563% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -10100.441% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -75645.731% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -89088.221% |
| Reflect Scientific, Inc. | 1.06 Million USD | -60784.329% |
| SmileDirectClub, Inc. | 517 Million USD | -25.265% |
| Sector 10, Inc. | 39.84 Thousand USD | -1625304.076% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 90.251% |
| SheerVision, Inc. | 2.33 Million USD | -27675.617% |
| United Health Products, Inc. | 2.42 Million USD | -26589.289% |
| Vasamed, Inc. | 4.67 Million USD | -13759.147% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -25180.076% |
| Yubo International Biotech Limited | 1.25 Million USD | -51385.72% |